Cambrooke Therapeutics, Inc. announced it has changed its corporate name to Ajinomoto Cambrooke, Inc. effective April 1, 2019.
In November 2017, Cambrooke became part of Ajinomoto Group when acquired by Ajinomoto Health & Nutrition North America, Inc. Cambrookes headquarters and production facilities will remain in Massachusetts. Ajinomotos North Carolina production facility will continue to supply Cambrookes pharmaceutical-grade amino acids.
For almost 20 years, Cambrooke has been a global leader and innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy. Since its acquisition, Cambrooke has continued its market-leading innovation while benefitting from Ajinomotos global nutrition and ingredient sciences expertise and proven flavor and texture enhancing R&D capabilities. Ajinomotos expertise has helped Cambrooke further fulfill its mission of improving lives by providing the most delicious and most nutritious medical foods for people with chronic health conditions.
Our name change reflects the myriad of benefits Ajinomoto helps us to deliver to our customers, says Howard Lossing, Cambrookes CEO. Ajinomotos Eat Well. Live Well. slogan is an elegant summary statement of our mission. Together, we are bringing the best tasting assortment of specialized nutrition products to those we serve.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Date: April 08, 2019
Source: Global Banking & Finance Review